Subject: MLCG Exhibits at 1st Annual Vapor Dynasty in AZ

SCV Client Spotlight
MLCG Exhibits at 1st Annual Vapor Dynasty in AZ
Hot Stock to WatchHot Stock to Watch

Company: ML Capital Group, Inc. (OTCQB: MLCG)

End of Day:

Price: 0.0059

Change (%): - 0.0004 (6.35)

Volume: 102,500
MLCG Chart

ML Capital Group to Exhibit at 1st Annual Vapor Dynasty Expo From October 24-26 at Phoenix Convention Center

FOUNTAIN HILLS, AZ-(Marketwired - Oct 14, 2014) - ML Capital Group, Inc. (OTCQB: MLCG), owner of the SuperStar Vapor Pen™, the SuperStar Dispensaries smart phone application, and SuperStar Medical Marijuana Recipe Book, is pleased to announce it will be an exhibitor at the upcoming first annual Vapor Dynasty Expo in Phoenix, Arizona from October 24 through October 26, 2014. Over 150 exhibitors from all over the world are expected to present at this widely anticipated event. The event is also referred to as the “Electronic Cigarette Expo”.

ML Capital Group CEO Lisa Nelson stated, “We look forward to this wonderful opportunity to further market and expose our products. We expect to incur new orders for product, add resellers, and create new relationships with stores that will offer our branded offerings.”

Continue Reading

Top PerformerYesterday's Top Performer

PositiveID Corporation (OTCQB: PSID)

End of Day:

Price: 0.073

Change (%): + 0.0261 (55.65)

Volume: 33,661,646

About PositiveID Corporation

PositiveID Corporation is an emerging growth company and developer of biological detection systems for America's homeland defense industry as well as rapid biological testing. PositiveID is focused on the development of microfluidic systems for the automated preparation of and performance of biological assays in order to detect biological threats at high-value locations, as well as analyze samples in a medical environment.

Company Information Sheet

Other Small Cap News

Company: Pazoo, Inc. (OTCQB: PZOO)

Pazoo Signs Online Marketing Agreement With MobileSeed LLC

WHIPPANY, NJ--(Marketwired - Oct 14, 2014) - Pazoo, Inc. (OTCQB: PZOO) (German WKN#: A1J3DK) is pleased to announce that it has signed a one year marketing contract with MobileSeed LLC. MobileSeed LLC will help to increase Pazoo's online presence, in particular through social media marketing and search engine optimization.

Joe Giovannoli, Head of Business Development at MobileSeed LLC, stated, "MobileSeed is very excited to be working with Pazoo, Inc. We will be aiding Pazoo in their efforts to increase organic traffic to the website through search engine optimization (SEO). We also are developing a social media campaign that will engage and influence Facebook and Twitter users to visit We look forward to a long, healthy relationship between MobileSeed and Pazoo."

Continue Reading

Company: Nuvilex, Inc. (OTCQB: NVLX)

Nuvilex's Cancer Treatment Obtaining FDA Orphan Drug Status Would Make Company Attractive Big Pharma Target

NEW YORK, NY--(Marketwired - October 14, 2014) - Nuvilex, Inc. (OTCQB: NVLX) has officially introduced its advanced pancreatic cancer treatment to the U.S. Food and Drug Administration (FDA) in an application asking the agency to grant orphan drug status to its Cell-in-a-Box®/ifosfamide combination for the rare disease.

The FDA's orphan drug program designates a special status to drugs and biologics intended to treat, diagnose, or prevent diseases and disorders that affect fewer than 200,000 people in the U.S. In the United States and Europe, where Nuvilex also applied for the orphan drug designation, it's easier to gain marketing approval with an orphan drug or biologic. If Nuvilex is granted orphan drug status in the U.S. and Europe, the company would enjoy 7 and 10 years, respectively, of marketing its pancreatic cancer treatment without any competition.

Continue Reading

Market News

By Jeff Macke: Yahoo Finance

Nightmare on Wall Street: Will the market bloodbath continue?

The beatings will continue until morale improves. Yesterday's close was a nightmare for premature dip buyers. The S&P 500 lost 1.65% on the day, all of it coming in the last two hours. At this point the most obvious catalyst for the selling is selling itself: institutions were afraid of stocks not holding support so they tried to beat the rush out of equities. The rout was on into the close.

The S&P 500 is now below the 200 day moving average for the first time since 2012 and off 6.8% from recent closing highs. Our next support comes at about 1,850 where we started the year.

By way of fundamental news the banks report this morning but don't expect much help there. It's a little like desperately searching for a cop and finding Barney Fife. JPMorgan (JPM), Citigroup (C) and Wells Fargo (WFC) report today. JPMorgan apparently accidentally released early and missed by a couple cents but it was quickly retracted. Regardless, as I believe I was the first to go on record as saying: earnings from banks don't matter. It's the tone and outlook.

Continue Reading


Cramer's 10 steps to a market rally

Ever since the top of the market formed with Alibaba (BABA) going public, it seems everything that could go wrong has. The rally on Monday was short-lived, as the S&P 500 closed down at least 1 percent in three consecutive sessions. The Dow Jones industrial average fell 223 points, or 1.35 percent and the S&P 500 fell 31 points, or 1.65 percent.

"Mad Money" host Jim Cramer reiterates this is a treacherous market-as the market couldn't hold even after the Fed indicated there is no hurry to raise rates; there was a good China export number for September; and there were peace rumblings in Ukraine. So rather than join the panic, Cramer gives his fans 10 steps of how to stem the market.

No. 1 Containment of Ebola
The fear has become so strong that some are expecting a SARS-like cut back in travel, and that was an airborne contracted pandemic. Ebola is bringing a sense of panic, especially when the lead story in the Wall Street Journal is "Ebola Case Puts Focus on Safeguards." Likewise, American Airline (AAL)'s stock peaked in June at $44, and has been going down since then and is now at $28. Cramer thinks it's reasonable to presume this gain for American Airlines could disappear because there has been so many conflicting reports. If there is another Ebola victim, he says we could be down even worse from these levels.

Continue Reading

Like Us on FacebookFollow Us on Twitter

SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to, Inc. by companies featured on our website or in our e-mail communications.

About Penny Stocks